CNR Institutional Research Information System

DEL VECCHIO, SILVANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.358
NA - Nord America 724
EU - Europa 245
SA - Sud America 211
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 690
SG - Singapore 587
CN - Cina 335
BR - Brasile 177
HK - Hong Kong 112
VN - Vietnam 109
FR - Francia 83
KR - Corea 77
NL - Olanda 43
IT - Italia 39
JP - Giappone 32
BD - Bangladesh 29
DE - Germania 26
IN - India 16
AR - Argentina 15
CA - Canada 14
FI - Finlandia 14
GB - Regno Unito 14
IL - Israele 10
MX - Messico 8
IQ - Iraq 7
SA - Arabia Saudita 7
PK - Pakistan 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
EC - Ecuador 5
CL - Cile 4
CO - Colombia 4
IE - Irlanda 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EG - Egitto 3
ES - Italia 3
ET - Etiopia 3
LA - Repubblica Popolare Democratica del Laos 3
PL - Polonia 3
PY - Paraguay 3
RU - Federazione Russa 3
SE - Svezia 3
TR - Turchia 3
TT - Trinidad e Tobago 3
CR - Costa Rica 2
ID - Indonesia 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
TW - Taiwan 2
UA - Ucraina 2
AT - Austria 1
BB - Barbados 1
CI - Costa d'Avorio 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.556
Salva come PNG Salva come JPEG
Città #
Singapore 354
Santa Clara 295
Hefei 158
Hong Kong 112
San Jose 101
Ashburn 77
Seoul 77
Beijing 76
Lauterbourg 69
Ho Chi Minh City 41
Los Angeles 31
Hanoi 23
Tokyo 22
Naples 13
Dallas 12
Frankfurt am Main 11
Helsinki 10
Minamishinagawa 10
Buffalo 9
São Paulo 9
New York 8
Orem 7
Munich 6
Tashkent 6
Belo Horizonte 5
Bengaluru 5
Brasília 5
Brooklyn 5
Can Tho 5
Rio de Janeiro 5
Springfield 5
Baghdad 4
Bauru 4
Biên Hòa 4
Dublin 4
Düsseldorf 4
Jeddah 4
Nha Trang 4
Poplar 4
Thái Bình 4
Amsterdam 3
Atlanta 3
Baku 3
Benito Juarez 3
Casandrino 3
Chicago 3
Curitiba 3
Da Nang 3
Guangzhou 3
Joinville 3
Jundiaí 3
London 3
Manaus 3
Milan 3
Quận Một 3
Riyadh 3
Stockholm 3
Turku 3
Addis Ababa 2
Amman 2
Aracaju 2
Bari 2
Belleville 2
Bonito 2
Campos dos Goytacazes 2
Caruaru 2
Catanduva 2
Charlotte 2
Chennai 2
Criciúma 2
Dhaka 2
Faisalabad 2
Fortaleza 2
Giza 2
Guayaquil 2
Haiphong 2
Istanbul 2
Johannesburg 2
Karachi 2
Lahore 2
Lang Son 2
Lanús 2
Manila 2
Memphis 2
Montreal 2
Ninh Bình 2
Osasco 2
Ottawa 2
Panama City 2
Paris 2
Porto 2
Queens 2
Quito 2
Recife 2
Riga 2
Salvador 2
Santiago de Cali 2
Seattle 2
Shanghai 2
Sorocaba 2
Totale 1.746
Salva come PNG Salva come JPEG
Nome #
IN VITRO AND IN VIVO CHARACTERIZATION OF INDIUM-111 AND TECHNETIUM-99M LABELED CCK-8 DERIVATIVES FOR CCK-B RECEPTOR IMAGING. 94
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 84
18F-FLT PET/CT imaging and inhibition of multiple signaling pathways downstream EGFR and MET receptors in resistant NSCLC 74
Bone Scintigraphy and SPECT/CT in Bisphosphonate-Induced Osteonecrosis of the Jaw 66
Gefitinib, a selective, tyrosine kinase inhibitor increases 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells. 65
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by F-18-fluorothymidine 65
Molecular imaging of tumor microenvironment FOREWORD 63
Multimodal imaging of tumor invasion by targeting integrin ?v?3 in a preclinical model of lung metastasis 63
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 55
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 54
Preclinical imaging for targeting cancer immune evasion 52
Bone Marrow uptake of 99mTc-MIBI in patients with multiple myeloma 49
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer. 45
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 43
Preclinical Imaging in Targeted Cancer Therapies 43
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer 43
Monitoring the effects of combined treatment with EGFR and MET inhibitors in non-small cell lung cancer and synergy quantification by 18F-FLT PET/CT 42
PET/CT in cancer research: from preclinical to clinical applications 40
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 40
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 39
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 38
99mTc-MIBI in the evaluation of breast cancer biology 38
18F-FLT PET/CT imaging of inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer 37
Preclinical imaging in oncology: advances and perspectives 37
Combined 18F-FDG-PET/CT and 111In-Octreotide SPECT for Evaluation of Thymic Epithelial Tumors 37
Usefulness of [In-111-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease 37
Poorly diifferentiated small cell neuroendocrinecarcinoma localized in three different endocrine glands: Response to chemoteraphy and octreotide LAR. 36
18F-FLT PET/CT as a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 36
MIBI as prognostic factor in breast cancer. 35
Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives 35
PET/CT in radiation oncology 35
Radiolabeling approaches for cholecystokinin B receptor imaging 34
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease. 34
Evaluation of metabolic response with F-18-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors 33
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells 33
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma 32
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 32
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 31
Nuclear imaging of apoptosis in animal tumor models 31
Targeting avb3 integrin receptor by a new and selective peptide antagonist for tumour imaging and radionuclide therapy 31
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 30
Nuclear imaging in cancer theranostics 30
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 30
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. 30
Molecular imaging of drug resistance in cancer 30
Dynamic coupling of 99mtc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 29
A New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 28
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 28
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 28
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-X-L modulation of inositol trisphosphate receptor type 3 27
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 27
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 27
Washout of 99mTc-Sestamibi in predicting response to chemoterapy in patients with multiple myeloma 27
99mTc-MIBI in the evaluation of breast cancer biology 26
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 26
Inhibition of early (99m)Tc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma 26
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines 26
Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma 26
Bone Scintigraphy and SPECT/CT in Bisphosphonate-Induced Osteonecrosis of the Jaw 26
Use of 99mTc-sestamibi scintigraphy in multiple myeloma. 26
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 25
Technetium 99m sestamibi in multiple myeloma 25
A new role for nuclear medicine in multiple myeloma 24
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. 23
PET/CT in cancer research: from preclinical to clinical applications 23
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 23
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 22
Molecular imaging of tumor microenvironment: challenges and perspectives 21
A NEW AND SELECTIVE RADIOLABELLED v 3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS 16
Totale 2.566
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.453
article - articoli 7.214
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 251
Totale 15.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202429 0 0 0 0 0 0 0 0 1 7 16 5
2024/20251.055 4 5 77 47 297 24 47 16 30 62 236 210
2025/20261.482 103 158 126 215 285 59 238 50 83 91 74 0
Totale 2.566